Conatus Pharmaceuticals Inc (NASDAQ:CNAT)

5.19
Delayed Data
As of 10:13am ET
 +0.022 / +0.43%
Today’s Change
5.13
Today|||52-Week Range
11.74
-25.83%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Conatus Pharmaceuticals Inc have a median target of 14.00, with a high estimate of 17.00 and a low estimate of 9.00. The median estimate represents a +169.65% increase from the last price of 5.19.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Conatus Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.35
Sales
$0.00
Reporting Date
Aug 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.27%
 
 
 
 
 
 
Growthannually -12.20%
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account